NCT04535245View on ClinicalTrials.gov

Lung Clearance Index to Identify Scleroderma Patients at Risk for ILD

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

January 15, 2026

Study Completion Date

January 15, 2026

Conditions
Scleroderma
Interventions
DIAGNOSTIC_TEST

LCI testing

all subjects will have LCI testing then contacted via a phone interview or EMR review yearly times 5 to determine if they have subsequently developed ILD

Trial Locations (1)

80206

RECRUITING

National Jewish Health, Denver

All Listed Sponsors
lead

National Jewish Health

OTHER